Polymorphic forms of icotinib and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9611272
APP PUB NO 20160108055A1
SERIAL NO

14896992

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the polymorphic forms of the compound of Formula I, preparation thereof and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder or a condition, or in the manufacturing of a medicament for the treatment of a disease, a disorder or a condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BETTA PHARMACEUTICALS CO LTD355 XINGZHONG ROAD YUHANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE HANGZHOU ZHEJIANG 311100 HANGZHOU CITY ZHEJIANG PROVINCE 311100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ding, Lieming Zhejiang, CN 45 36
Hu, Shaojing Beijing, CN 32 264
Long, Wei Beijing, CN 91 553
Wang, Fei Beijing, CN 1116 10607
Wang, Yinxiang Beijing, CN 19 59

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00